TY - JOUR
T1 - Irreversible electroporation in locally advanced pancreatic cancer: A call for standardization of energy delivery
AU - Martin, Robert C. G.
AU - Durham, Alan North
AU - Besselink, Marc G.
AU - Iannitti, David
AU - Weiss, Matthew J.
AU - Wolfgang, Christopher L.
AU - Huang, Kai-Wen
PY - 2016
Y1 - 2016
N2 - Irreversible Electroporation (IRE) is used to treat locally advanced cancers, commonly of the pancreas, liver, kidney, and other soft tissues. Precise eligibility for IRE should be established in each individual patient by a multidisciplinary team based on comprehensive clinical, imaging, and laboratory assessment. Standardization of IRE technique and protocols is expected to improve safety, lead to reproducible outcomes, and facilitate further research into IRE. The present article provides a set of technical recommendations for the use of IRE in the treatment of locally advanced pancreatic cancer. J. Surg. Oncol. 2016;114:865-871. © 2016 2016 Wiley Periodicals, Inc
AB - Irreversible Electroporation (IRE) is used to treat locally advanced cancers, commonly of the pancreas, liver, kidney, and other soft tissues. Precise eligibility for IRE should be established in each individual patient by a multidisciplinary team based on comprehensive clinical, imaging, and laboratory assessment. Standardization of IRE technique and protocols is expected to improve safety, lead to reproducible outcomes, and facilitate further research into IRE. The present article provides a set of technical recommendations for the use of IRE in the treatment of locally advanced pancreatic cancer. J. Surg. Oncol. 2016;114:865-871. © 2016 2016 Wiley Periodicals, Inc
U2 - https://doi.org/10.1002/jso.24404
DO - https://doi.org/10.1002/jso.24404
M3 - Article
C2 - 27546233
SN - 0022-4790
VL - 114
SP - 865
EP - 871
JO - Journal of surgical oncology
JF - Journal of surgical oncology
IS - 7
ER -